A detailed history of Frank, Rimerman Advisors LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 2,835 shares of WST stock, worth $947,627. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,835
Previous 2,859 0.84%
Holding current value
$947,627
Previous $941,000 9.67%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$277.16 - $333.3 $6,651 - $7,999
-24 Reduced 0.84%
2,835 $850,000
Q2 2024

Aug 13, 2024

BUY
$314.68 - $395.94 $899,670 - $1.13 Million
2,859 New
2,859 $941,000
Q2 2022

Sep 07, 2023

SELL
$280.61 - $420.45 $701,244 - $1.05 Million
-2,499 Closed
0 $0
Q4 2021

Sep 07, 2023

BUY
$402.25 - $471.34 $181,817 - $213,045
452 Added 22.08%
2,499 $1.17 Billion
Q3 2021

Sep 07, 2023

BUY
$363.01 - $468.47 $743,081 - $958,958
2,047 New
2,047 $869 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Frank, Rimerman Advisors LLC Portfolio

Follow Frank, Rimerman Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frank, Rimerman Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frank, Rimerman Advisors LLC with notifications on news.